UTP14A Antibody
-
中文名稱：UTP14A兔多克隆抗體
-
貨號：CSB-PA883609ESR1HU
-
規格：￥440
-
其他：
產品詳情
-
產品名稱：Rabbit anti-Homo sapiens (Human) UTP14A Polyclonal antibody
-
Uniprot No.：
-
基因名：UTP14A
-
別名：UTP14A antibody; SDCCAG16 antibody; U3 small nucleolar RNA-associated protein 14 homolog A antibody; Antigen NY-CO-16 antibody; Serologically defined colon cancer antigen 16 antibody
-
宿主：Rabbit
-
反應種屬：Human
-
免疫原：Recombinant Human U3 small nucleolar RNA-associated protein 14 homolog A protein (1-260AA)
-
免疫原種屬：Homo sapiens (Human)
-
標記方式：Non-conjugated
-
克隆類型：Polyclonal
-
抗體亞型：IgG
-
純化方式：Antigen Affinity Purified
-
濃度：It differs from different batches. Please contact us to confirm it.
-
保存緩沖液：PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
-
產品提供形式：Liquid
-
應用范圍：ELISA
-
Protocols：
-
儲存條件：Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期：Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
-
用途：For Research Use Only. Not for use in diagnostic or therapeutic procedures.
產品評價
相關產品
靶點詳情
-
功能：May be required for ribosome biogenesis.
-
基因功能參考文獻：
- The hUTP14a protected tumor cells from chemotherapeutic drug-induced apoptosis and thus might possess a potential as a target for anti-tumor therapy. PMID: 28672776
- The positivity rate of hUTP14a expression was significantly higher in HCC specimens. Positive expression of nucleolar hUTP14a might act as a novel prognostic predictor for patients with HCC PMID: 28218222
- hUTP14a physically interacts with p53 and functionally promotes p53 turn-over PMID: 21078665
-
亞細胞定位：Nucleus, nucleolus.
-
蛋白家族：UTP14 family
-
組織特異性：Ubiquitously expressed.
-
數據庫鏈接：
Most popular with customers
-
YWHAB Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC, IF, FC
Species Reactivity: Human, Mouse, Rat
-
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human
-
-
-
-
-
-
